Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

Diabetes Care. 2001 Feb;24(2):284-9. doi: 10.2337/diacare.24.2.284.

Abstract

Objective: To determine the incidence of retinopathy and the relative importance of its risk factors in type 1 diabetes.

Research design and methods: This is a 7.3-year follow-up of 764 of 1,215 (63%) people with type 1 diabetes across Europe, aged 15-60 years at baseline with no retinopathy (the EURODIAB Prospective Complications Study). Retinal photographs were taken at baseline and follow-up and risk factors were assessed to a standard protocol.

Results: Retinopathy incidence was 56% (429/764, 95% CI 52-59%). Key risk factors included diabetes duration and glycemic control. We found no evidence of a threshold effect for HbA1c on retinopathy incidence. Univariate associations were observed between incidence and albumin excretion rate, cholesterol, triglyceride, fibrinogen, von Willebrand factor, gamma-glutamyltransferase, waist-to-hip ratio, and insulin dose. No associations were observed for blood pressure, cardiovascular disease, or smoking. Independent risk factors, as assessed by standardized regression effects, were HbA1C (1.93, P = 0.0001), duration (1.32, P = 0.008), waist-to-hip ratio (1.32, P = 0.01), and fasting triglyceride (1.24, P = 0.04).

Conclusions: Retinopathy incidence in type 1 diabetes remains high. Key risk factors include diabetes duration and glycemic control, with no evidence of a threshold for the latter. Other independent risk factors, such as waist-to-hip ratio and triglyceride levels, both markers of insulin resistance, were strongly related to incidence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Albuminuria
  • Biomarkers / analysis*
  • Body Constitution
  • Cholesterol / blood
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / epidemiology
  • Fasting
  • Fibrinogen / analysis
  • Follow-Up Studies
  • Glycated Hemoglobin / analysis
  • Humans
  • Insulin / administration & dosage
  • Insulin Resistance*
  • Logistic Models
  • Middle Aged
  • Risk Factors
  • Triglycerides / blood
  • gamma-Glutamyltransferase / blood
  • von Willebrand Factor / analysis

Substances

  • Biomarkers
  • Glycated Hemoglobin A
  • Insulin
  • Triglycerides
  • von Willebrand Factor
  • Fibrinogen
  • Cholesterol
  • gamma-Glutamyltransferase